The prognostic role of 1q21 gain/amp in newly diagnosed multiple myeloma: the faster, the worse

被引：0
|
作者：
Wang, Yawen [1 ]
Xu, Jiadai [1 ]
Liu, Peng [1 ]
Li, Panpan [1 ]
机构：
[1] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-227
引用
收藏
页码：S160 / S160
页数：1
相关论文
共 50 条
  • [1] The prognostic role of 1q21 gain/amplification in newly diagnosed multiple myeloma: The faster, the worse
    Wang, Yawen
    Xu, Jiadai
    Xu, Bei
    Li, Panpan
    Yang, Yang
    Wang, Wenjing
    Xu, Tianhong
    Maihemaiti, Aziguli
    Lan, Tianwei
    Wang, Pu
    Ren, Liang
    Zhou, Chi
    Aihemaiti, Xianmuseye
    Liu, Peng
    CANCER, 2023, 129 (07) : 1005 - 1016
  • [2] The independent adverse prognostic significance of 1q21 gain in newly diagnosed multiple myeloma patients
    Fu, Chengcheng
    You, Hongying
    Yan, Shuang
    Pan, Jinlan
    Yao, Weiqin
    Shang, Jingjing
    Shi, Xiaolan
    Jin, Song
    Yan, Lingzhi
    Wu, Deipei
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S70 - S70
  • [3] Efficacy Analysis of Bortezomib Combined with Lenalidomide in Newly Diagnosed Multiple Myeloma with 1q21 Gain/Amp
    Zhou, Qiaolin
    Wen, Jingjing
    Xu, Fang
    Yue, Jing
    Zhang, Ya
    Su, Jing
    Liu, Yiping
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [4] Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain
    Iriuchishima, Hirono
    Saito, Akio
    Mihara, Masahiro
    Terasaki, Yukie
    Matsumoto, Akira
    Isoda, Atsushi
    Furukawa, Yusuke
    Matsumoto, Morio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 71 - 79
  • [5] The Independent Adverse Prognostic Significance of 1q21 Gain/Amplification in Newly Diagnosed Multiple Myeloma Patients
    You, Hongying
    Jin, Song
    Wu, Chunxiao
    Wang, Qingqing
    Yan, Shuang
    Zhai, Yingying
    Yao, Weiqin
    Shi, Xiaolan
    Shang, Jingjing
    Yan, Lingzhi
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Pan, Jinlan
    Wu, Depei
    Fu, Chengcheng
    BLOOD, 2022, 140 : 10056 - 10057
  • [6] The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients
    You, Hongying
    Jin, Song
    Wu, Chunxiao
    Wang, Qingqing
    Yan, Shuang
    Yao, Weiqin
    Shi, Xiaolan
    Shang, Jingjing
    Yan, Lingzhi
    Yao, Ying
    Wang, Jing
    Wang, Panfeng
    Pan, Jinlan
    Wu, Depei
    Fu, Chengcheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Amp 1q21 is more predictable with dismal survival than gain 1q21 of newly diagnosed multiple myeloma in real-world analysis
    Wang, Yu-Tong
    Bao, Li
    Chu, Bin
    Chen, Xiao-Huan
    Lu, Min-Qiu
    Shi, Lei
    Gao, Shan
    Fang, Li-Juan
    Xiang, Qiu-Qing
    Ding, Yue-Hua
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (07)
  • [8] Gain of 1q21 in multiple myeloma: from bad to worse?
    Sonneveld, Pieter
    BLOOD, 2006, 108 (05) : 1426 - 1427
  • [9] Prognostic Value of 1q21 Gain in Multiple Myeloma
    Chen, Dangui
    Zhou, Di
    Xu, Jingyan
    Zhou, Rongfu
    Ouyang, Jian
    Chen, Bing
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (03): : E159 - E164
  • [10] The Role of 1q21 Gain on the Prognosis of Multiple Myeloma
    Dong Hui Xing
    Jin Huan Wang
    Zhi Gang Zhao
    Journal of Nutritional Oncology, 2021, 6 (02) : 50 - 56
12345